Concepedia

Talia Gileadi

TG

Statistics

Publications

7

Citations

568

H-Index

7

Active since

2017

Affiliations

University College London(Current)

Cancer Research UK

CRUK Lung Cancer Centre of Excellence

Centre National de la Recherche Scientifique

Institut des Neurosciences Paris-Saclay

Talia Gileadi is an author at University College London specializing in cancer immunotherapy, oncology, and immunotherapy.

Publications per year

2017–2023

7

Publications

7

Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation

Anna Capsomidis, Gabriel Benthall, Heleen H. Van Acker et al. · Molecular Therapy · 2017 · 262 citations · Full text

Life Sciences, Immunology, Oncology +17

Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma

Karin Straathof, Barry Flutter, Rebecca Wallace et al. · Science Translational Medicine · 2020 · 205 citations

Life Sciences, Immunology, Oncology +17

Effects of Low-Dose Gestational TCDD Exposure on Behavior and on Hippocampal Neuron Morphology and Gene Expression in Mice

Talia Gileadi, Abhyuday K. Swamy, Zoe Hore et al. · Environmental Health Perspectives · 2021 · 26 citations · Full text

Pharmacy, Neuroscience, Toxicology +17

Abstract CT145: A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma

Karin Straathof, Barry Flutter, Rebecca Wallace et al. · Cancer Research · 2018 · 25 citations

Life Sciences, Immunology, Oncology +11

Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells

Emma Halliwell, Alice Vitali, Henrike Muller et al. · Cytotherapy · 2022 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +14

1–5 of 7